137 related articles for article (PubMed ID: 1819211)
1. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study.
Donati D; Degiannis D; Homer L; Raska K; Raskova J
Am J Nephrol; 1991; 11(6):451-8. PubMed ID: 1819211
[TBL] [Abstract][Full Text] [Related]
2. Production of cytokines in hemodialysis.
Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
[TBL] [Abstract][Full Text] [Related]
3. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 kinetics in hemodialysis.
Donati D; Degiannis D; Homer L; Raska K; Raskova J
ASAIO Trans; 1991; 37(3):M391-2. PubMed ID: 1751203
[TBL] [Abstract][Full Text] [Related]
6. Influence of dialysis membranes on interleukin-1 beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells.
Higuchi T; Kuno T; Takahashi S; Kanmatsuse K
Artif Organs; 1997 Apr; 21(4):265-71. PubMed ID: 9096797
[TBL] [Abstract][Full Text] [Related]
7. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
[TBL] [Abstract][Full Text] [Related]
8. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
[TBL] [Abstract][Full Text] [Related]
9. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS).
Laude-Sharp M; Caroff M; Simard L; Pusineri C; Kazatchkine MD; Haeffner-Cavaillon N
Kidney Int; 1990 Dec; 38(6):1089-94. PubMed ID: 2127434
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptors and receptor antagonist in haemodialysis.
Donati D; Degiannis D; Mazzola E; Gastaldi L; Raskova J; Raska K; Camussi G
Nephrol Dial Transplant; 1997 Jan; 12(1):111-8. PubMed ID: 9027784
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.
Lin YF; Chang DM; Shaio MF; Lu KC; Chyr SH; Li BL; Sheih SD
Am J Nephrol; 1996; 16(4):293-9. PubMed ID: 8739281
[TBL] [Abstract][Full Text] [Related]
12. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release.
Donati D; Degiannis D; Homer L; Gastaldi L; Raskova J; Raska K
Nephron; 1991; 58(3):268-75. PubMed ID: 1896091
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic hemodialysis patients.
Rostaing L; Peres C; Tkaczuk J; Charlet JP; Bories P; Durand D; Ohayon E; de Préval C; Abbal M
Am J Nephrol; 2000; 20(1):18-26. PubMed ID: 10644863
[TBL] [Abstract][Full Text] [Related]
14. The effects of hemodialysis (HD) membranes on interleukin 1-beta (IL-1 beta) production from peripheral blood mononuclear cells (PBMC).
Momoi T; Ono M; Takagi T; Sugiura S; Ogawa H; Saito A
Clin Nephrol; 1995 Nov; 44 Suppl 1():S24-8. PubMed ID: 8608657
[TBL] [Abstract][Full Text] [Related]
15. Hemodialysis with cuprophane or polysulfone: effects on uremic polyneuropathy.
Robles NR; Murga L; Galvan S; Esparrago JF; Sanchez-Casado E
Am J Kidney Dis; 1993 Mar; 21(3):282-7. PubMed ID: 8383423
[TBL] [Abstract][Full Text] [Related]
16. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
Mrowka C; Heintz B; Sieberth HG
Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
19. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients.
Gu Y; Ding F; Qin H; Zhao H; Lin S
Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226
[TBL] [Abstract][Full Text] [Related]
20. Reduction of mononuclear cytokine production in hemodialysis patients treated with steam-sterilized low-flux polysulphone membranes.
Aucella F; Vigilante M; Grandone E; Colaizzo D; Margaglione M; Modoni S; Orlandini G; Stallone C
Int J Artif Organs; 1998 Apr; 21(4):210-5. PubMed ID: 9649062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
